Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents
1
Organic Chemistry Lab., Faculty of Specific Education, Ain Shams University
|
3
Organic Chemistry Dep., Faculty of Science, Ain Shams University
|
Publication type: Journal Article
Publication date: 2018-03-31
scimago Q3
wos Q3
SJR: 0.349
CiteScore: 2.7
Impact factor: 1.3
ISSN: 00092363, 13475223
PubMed ID:
29607908
General Chemistry
Drug Discovery
General Medicine
Abstract
A set of novel series of 1,3,4-thiadiazolyl-sulfanyl-4,5-dihydropyridazin-3(2H)-ones with anticipated antimicrobial activity has been synthesized. The synthetic protocol of the targeted compounds was accomplished by treating β-aroylacrylic acid 1 with 5-amino-1,3,4-thiadiazole-2-thiol (2) to afford the thia-Michael adduct 3. Afterwards, the obtained thia-Michael adduct 3 was cyclized to 4,5-dihydropyridazin-3(2H)-ones 4a-d and the non-cyclized product hydrazone 5 by using different hydrazines. Moreover, adduct 3 was reacted with esters like diethyl malonate and ethyl acetoacetate affording 1,3,4-thiadiazolobutanamides 6a, b. Furthermore, the concurrent reaction of later butamides 6a, b with the hydrazine derivatives furnished thiadiazolopyridazin-3(2H)-ones 7a-d, 8, and butanoic acid 9.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Journal of Organic Chemistry
2 publications, 18.18%
|
|
|
Journal of Molecular Structure
2 publications, 18.18%
|
|
|
Chemistry - A European Journal
1 publication, 9.09%
|
|
|
Synthetic Communications
1 publication, 9.09%
|
|
|
Drug Research
1 publication, 9.09%
|
|
|
Mendeleev Communications
1 publication, 9.09%
|
|
|
Journal of Physical Chemistry A
1 publication, 9.09%
|
|
|
Advances in Heterocyclic Chemistry
1 publication, 9.09%
|
|
|
1
2
|
Publishers
|
1
2
3
|
|
|
American Chemical Society (ACS)
3 publications, 27.27%
|
|
|
Elsevier
3 publications, 27.27%
|
|
|
Wiley
1 publication, 9.09%
|
|
|
Taylor & Francis
1 publication, 9.09%
|
|
|
Georg Thieme Verlag KG
1 publication, 9.09%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 9.09%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 9.09%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
11
Total citations:
11
Citations from 2025:
2
(18.18%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
El-Badry Y. A. et al. Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents // Chemical and Pharmaceutical Bulletin. 2018. Vol. 66. No. 4. pp. 427-433.
GOST all authors (up to 50)
Copy
El-Badry Y. A., Sallam M. S., El-Hashash M. A. Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents // Chemical and Pharmaceutical Bulletin. 2018. Vol. 66. No. 4. pp. 427-433.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1248/cpb.c17-00918
UR - https://doi.org/10.1248/cpb.c17-00918
TI - Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents
T2 - Chemical and Pharmaceutical Bulletin
AU - El-Badry, Yaser Abdel-Moemen
AU - Sallam, Mohammed Shafie
AU - El-Hashash, Mahr Abdel-Aziz
PY - 2018
DA - 2018/03/31
PB - Pharmaceutical Society of Japan
SP - 427-433
IS - 4
VL - 66
PMID - 29607908
SN - 0009-2363
SN - 1347-5223
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_El-Badry,
author = {Yaser Abdel-Moemen El-Badry and Mohammed Shafie Sallam and Mahr Abdel-Aziz El-Hashash},
title = {Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2018},
volume = {66},
publisher = {Pharmaceutical Society of Japan},
month = {mar},
url = {https://doi.org/10.1248/cpb.c17-00918},
number = {4},
pages = {427--433},
doi = {10.1248/cpb.c17-00918}
}
Cite this
MLA
Copy
El-Badry, Yaser Abdel-Moemen, et al. “Efficient 1,3,4-Thiadiazole-4,5-dihydropyridazin-3(2H)-ones as Antimicrobial Agents.” Chemical and Pharmaceutical Bulletin, vol. 66, no. 4, Mar. 2018, pp. 427-433. https://doi.org/10.1248/cpb.c17-00918.